rss
Heart 2009;95:1326-1330 doi:10.1136/hrt.2008.148429
  • Original article
  • Coronary artery disease

Peripheral blood stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute and old myocardial infarction for intracoronary cell infusion

  1. S-A Chang1,2,
  2. H-J Kang1,2,
  3. H-Y Lee1,2,
  4. K-H Kim1,
  5. J Hur1,
  6. K-S Han3,
  7. Y-B Park2,4,
  8. H-S Kim1,2,4
  1. 1
    National Research Laboratory for Cardiovascular Stem Cell, Seoul National University Hospital, Seoul, Republic of Korea
  2. 2
    Cardiovascular Center, Seoul National University Hospital, Seoul, Republic of Korea
  3. 3
    Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Republic of Korea
  4. 4
    Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul, Republic of Korea
  1. Professor Hyo-Soo Kim, Department of Internal Medicine, Seoul National University College of Medicine, 28 Yongon-dong Chongno-gu, Seoul, 110-744 Korea; hyosoo{at}snu.ac.kr
  • Accepted 2 December 2008
  • Published Online First 20 May 2009

Abstract

Background/aims: Peripheral blood stem cells (PBSC) are one of the most promising stem cell sources for treatment of ischaemic heart disease. However, the experience of mobilisation and collection of PBSC using granulocyte-colony stimulating factor (G-CSF) in patients with myocardial infarction (MI) is still limited. We report our experiences with the feasibility and safety of collection of mobilised PBSC with G-CSF in MI patients, and the influence of acute ischaemia on efficacy of PBSC collection.

Methods: 74 patients with acute or old myocardial infarction (AMI vs OMI, n = 46 and n = 28) underwent PBSC collection after administration of G-CSF twice a day at a dose of 5 μg/kg for 3 days. Flow cytometric analysis of cell surface markers was performed.

Results: No evidence of inflammation or ischaemia was observed during G-CSF mobilisation and PBSC collection. The yield of CD34+ cells was 12.9 (SD 15.92) ×109/l (5.04% (5.30%) of total cells) with a product volume of 37.9 (8.4) ml after 5650 (987) ml of blood were processed during PBSC collection. Stem cell mobilisation and collection by G-CSF is more efficient in AMI than in OMI, and proportions of cells positive for VE-cadherin or KDR/CD34 are significantly greater in AMI than in OMI (p<0.01).

Conclusion: We could obtain sufficient numbers of PBSC for intracoronary infusion with the G-CSF-based mobilisation strategy without complications even in patients with MI. PBSC collection after mobilisation with G-CSF is a safe and feasible method of stem cell collection for therapeutic purpose in patients with MI.

Footnotes

  • See Editorial, p 1301

  • ‣ Additional data are published online only at http://heart.bmj.com/content/vol95/issue16

  • S-AC and H-JK equally contributed to this work.

  • Funding: This study was supported by a grant from Stem Cell Research Center (SC4210 to YBP), and the Innovative Research Institute for Cell Therapy (to HSK).

  • Competing interests: None.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. Web only appendix
  5. All versions of this article:
    1. hrt.2008.148429v1
    2. 95/16/1326 most recent

Responses

  1. Submit a response
  2. No responses published

Latest from Education in Heart

Latest from Education in Heart

Register for free content


Free trial
Individuals may register for a free 60 day online trial to all content.

Free archive
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.